New MDGuidelines Duration Views Helps Return People to Work and
Health More Quickly

March 22, 2017 10:00 AM Eastern Daylight Time

WESTMINSTER, Colo.--(BUSINESS WIRE)--ReedGroup® has announced the launch of its new MDGuidelines® Duration
Views, a tool developed to estimate employees’ disability durations with
higher accuracy and increased transparency. MDGuidelines Duration Views
is built upon robust analytics, evidence from millions of real-world
cases, expert medical opinions, and MDGuidelines’ robust population
database. This revolutionary tool will provide additional information to
aid case managers and physicians in applying their professional judgment.

MDGuidelines Duration Views (accessible at mdguidelines.com)
adds to ReedGroup’s evidence-based care guidelines – a tool that can
dramatically impact healthcare costs, which grew to $3.2 trillion in the
U.S. in 2015 (The Centers for Medicare & Medicaid Services). In
addition, its increased accuracy is designed to help providers set
appropriate recovery goals for returning people to normal living and
optimize the use of healthcare services.

“ReedGroup is focused on changing the absence and disability industry,”
said ReedGroup CEO David Roberts. “As with our MDGuidelines Duration
Views, ReedGroup is innovating across all our products and services to
enable faster and safer return-to-activity for employees in work
settings and patients in clinical settings. This new tool demonstrates
ReedGroup’s commitment to deliver progressively more impactful data and
tools to support our customers in their decision making.”

“No other duration estimation tool includes this level of underlying
analytic rigor, bringing a new level of sophisticated analysis to the
healthcare industry,” said Fraser Gaspar, Ph.D., ReedGroup’s
Epidemiologist. “We applied advanced statistical techniques to improve
the existing predictive model and have made our comprehensive duration
estimates available in one place so clients can more quickly use and
apply our industry-leading content,” he added.

For the first time—more accurate disability duration data in one
place

MDGuidelines Duration Views arms clinicians and case managers with
multiple data points and perspectives, in a single view, so they can
make the best decisions and ultimately enable better health outcomes in
disability cases. The tool provides easy access to three comprehensive
yet distinct types of recovery estimates, making it the only “one-stop
shop” in the marketplace for providers, payers and employers. The three
views include:

Population View: Users can manage return-to-activity by comparing
cases to average durations experienced by other people with the same
condition – based on seven million real-world cases.

Case View: Users can predict durations on specific cases by
understanding influencing factors such as age, gender and comorbid
conditions.

MDGuidelines Duration Views includes a Summary View that allows users to
review all three estimates in a consolidated chart.

Underpinned by Rigorous Analytics

ReedGroup is committed to transparency in its methodology – a core
Institute of Medicine (IoM) requirement for any medical guideline.
MDGuidelines Duration Views includes an improved predictive model based
on proven and transparent statistical methodologies. View
the MDGuidelines Duration Views whitepaper, which offers insight
into ReedGroup’s methodology and statistics.

About ReedGroup

ReedGroup, a wholly owned subsidiary of the The Guardian Life Insurance
Company of America®, is a leading health and productivity organization
providing services to over half of the Fortune 100 companies. With more
than 2,000 employees, ReedGroup has operations across the United States,
Canada, and India. ReedGroup’s flagship product, MDGuidelines, is the
industry’s leading solution for total health management and workplace
productivity. MDGuidelines features the world’s most trusted disability
duration estimates and evidence-based Practice Guidelines from ACOEM.
MDGuidelines is a proven approach to managing and measuring the impact
of evidence-based care across entire populations.